KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Castle Biosciences (CSTL) over the last 4 years, with Q3 2025 value amounting to $48000.0.

  • Castle Biosciences' Other Non Operating Income changed N/A to $48000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year increase of 342.86%. This contributed to the annual value of -$1.4 million for FY2020, which is 12679.84% down from last year.
  • As of Q3 2025, Castle Biosciences' Other Non Operating Income stood at $48000.0.
  • In the past 5 years, Castle Biosciences' Other Non Operating Income registered a high of $48000.0 during Q3 2025, and its lowest value of $48000.0 during Q3 2025.